StockData
CNS Pharmaceuticals, Inc. logo

CNS Pharmaceuticals, Inc. (CNSP) stock

CNSPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$4.15+0.67 (+19.25%)

Close on Nov 17, 2026Market cap $6.07MP/E –Yield –

CNS Pharmaceuticals total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

CNS Pharmaceuticals's total debt was $482.38K at Dec 31, 2020. For fiscal 2020 it was $482.38K.

Annual total debt

PeriodPeriod endValueChange
FY2020Dec 31, 2020$482.38K–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2020Dec 31, 2020$482.38K–

More CNS Pharmaceuticals figures

See a number that looks wrong?